Patents Assigned to EMMYON, INC.
  • Furostan-3-ol derivatives as skeletal muscle hypertrophic agents
    Patent number: 11136348
    Abstract: Compounds of formula I are disclosed. The compounds are useful for promoting skeletal muscle hypertrophy or treating skeletal muscle atrophy.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: October 5, 2021
    Assignee: EMMYON, INC.
    Inventor: John J. Talley
  • FUROSTAN-3-OL DERIVATIVES AS SKELETAL MUSCLE HYPERTROPHIC AGENTS
    Publication number: 20200247840
    Abstract: Compounds of formula I are disclosed. The compounds are useful for promoting skeletal muscle hypertrophy or treating skeletal muscle atrophy.
    Type: Application
    Filed: April 17, 2020
    Publication date: August 6, 2020
    Applicant: EMMYON, INC.
    Inventor: John J. TALLEY
  • URSOLIC ACID MORPHOLINE AND DIETHANOLAMINE SALTS
    Publication number: 20200207802
    Abstract: The invention provides diethanolamine and morpholine salts of ursolic acid. Compositions containing the salts, and methods of using the salts are also provided.
    Type: Application
    Filed: March 6, 2020
    Publication date: July 2, 2020
    Applicant: EMMYON, INC.
    Inventor: John J. TALLEY
  • Furostan-3-ol derivatives as skeletal muscle hypertrophic agents
    Patent number: 10662219
    Abstract: Compounds of formula I are disclosed. The compounds are useful for promoting skeletal muscle hypertrophy or treating skeletal muscle atrophy.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: May 26, 2020
    Assignee: EMMYON, INC.
    Inventor: John J Talley
  • FUROSTAN-3-OL DERIVATIVES AS SKELETAL MUSCLE HYPERTROPHIC AGENTS
    Publication number: 20180305399
    Abstract: Compounds of formula I are disclosed. The compounds are useful for promoting skeletal muscle hypertrophy or treating skeletal muscle atrophy.
    Type: Application
    Filed: October 28, 2016
    Publication date: October 25, 2018
    Applicant: EMMYON, INC.
    Inventor: John J TALLEY